Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine for Pterygium
NCT01109056Phase 2Completed
- Sponsor
- Allergan
- Start
- Jun 2010
- Primary completion
- May 2011
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of cyclosporine ophthalmic solution in pterygium (2 arms), sponsored by Allergan. Primary endpoints: Number of Pterygium Hyperemia Responders at Week 16 and Change From Baseline in Severity Grade of Pterygium Hyperemia at Week 16. Started Jun 2010; status: completed.
02
Drugs
cyclosporine ophthalmic solution
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT01109056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109056.